Finance

Lists
Why is FTH down 9.32%?
Dive Deeper
FTH:NASDAQ
Faeth Therapeutics, Inc
$7.88
-9.32%
(-0.81) 1D
$7.88
0.00% (0.00)
After hours
Closed: Nov 20, 4:00:02 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FTH...
Open
$8.52
High
$9.13
Low
$7.84
Mkt. cap
203.65M
Avg. vol.
626.16K
Volume
419.11K
52-wk high
$42.14
52-wk low
$7.84
EPS
-$138.82
Beta
-0.13
Shares outstanding
25.84M
No. of employees
29
Open
$8.52
High
$9.13
Low
$7.84
Mkt. cap
203.65M
Avg. vol.
626.16K
Volume
419.11K
52-wk high
$42.14
52-wk low
$7.84
EPS
-$138.82
Beta
-0.13
Shares outstanding
25.84M
No. of employees
29
News stories
From web sources and news partners
About Faeth Therapeutics, Inc
CEO-
Employees29
Founded1999
HeadquartersAustin, Texas, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 9 analysts giving stock ratings to FTH in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for FTH in the last 3 months.
Highest
Current $7.88
$69.00 (+775.63%)
Average
$58.00 (+636.04%)
Lowest
$40.00 (+407.61%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$60.00
+661.4%
11/17/2026
Bradley Canino
Guggenheim
Buy
Maintained
$69.00
+775.6%
11/09/2026
Geoff Meacham
Citi
Buy
Reiterated
$60.00
+661.4%
11/10/2026
Dev Prasad
Lucid Capital
Buy
Maintained
$59.00
+648.7%
11/09/2026
Jeet Mukherjee
BTIG
Buy
Maintained
$55.00
+598%
11/09/2026
Boris Peaker
JonesTrading
Buy
Maintained
$55.00
+598%
11/03/2026
Unknown Analyst
William Blair
Buy
Initiated
$66.00
+737.6%
10/15/2026
Alethia Young
William Blair
Buy
Initiated
$66.00
+737.6%
10/15/2026
Sharon Zackfia
William Blair
Buy
Initiated
$66.00
+737.6%
10/15/2026
Oliver McCammon
LifeSci Capital
Buy
Initiated
$40.00
+407.6%
10/15/2026
Tara Bancroft
TD Cowen
Buy
Initiated
-
-
09/09/2026
Gil Blum
Needham
Buy
Initiated
$56.00
+610.7%
08/21/2026
Jay Olson
Oppenheimer
Buy
Maintained
$60.00
+661.4%
08/05/2026
Sean McCutcheon
Raymond James
Buy
Initiated
$56.00
+610.7%
07/31/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
$51.00
+547.2%
07/20/2026
Jack Allen
Robert W. Baird
Buy
Initiated
$57.00
+623.4%
06/26/2026
Li Watsek
Cantor Fitzgerald
Buy
Maintained
-
-
06/03/2026
Christopher Liu
Lucid Capital
Buy
Initiated
$50.00
+534.5%
05/28/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.17M
150.91M
9.18M
11.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.79M
19.71M
9.20M
10.35M
Operating expense
4.96M
170.63M
18.38M
22.09M
Total operating expenses
4.96M
170.63M
18.38M
22.09M
Operating income
-4.96M
-170.63M
-18.38M
-22.09M
Other non operating income
-115.00K
-104.00K
120.00K
-88.00K
EBT including unusual items
-4.72M
-170.24M
-16.01M
-20.40M
EBT excluding unusual items
-4.85M
-170.34M
-16.01M
-20.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.72M
-170.24M
-16.01M
-20.40M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-0.79
Interest and investment income
223.00K
392.00K
2.26M
1.78M
Interest expense
-3.00K
-
-
-
Net interest expenses
220.00K
392.00K
2.26M
1.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
-4.92M
-170.60M
-18.36M
-22.07M
Gain or loss from assets sale
-21.00K
-
-
30.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps